Medicare Advantage (MA) plans are facing both regulatory and business risks following the conclusion of the COVID-19 Public Health Emergency (PHE). What are the major MA flexibilities and requirements related to the pandemic, and have they ended along with the PHE?
Medicare Advantage Plan Requirements Post-PHE: Ensuring a Smooth Transition
By Brian Stimson and Fabiola Díaz Vera on June 6, 2023
Posted In Employee Benefits, Health and Welfare Plans
Brian Stimson
Brian Stimson is the former Acting General Counsel and Principal Deputy General Counsel (second-ranking lawyer) for the US Department of Health and Human Services (HHS) in Washington, DC. He represents health and life sciences clients in litigations, arbitrations and government investigations nationwide. As part of his practice, Brian counsels clients on how to navigate complex disputes that present overlapping legal, regulatory, public policy and business considerations. His collaborative and pragmatic approach draws on his work as a high-level HHS official and a litigator. Read Brian Stimson's full bio.
Fabiola Díaz Vera
Fabiola Díaz Vera counsels healthcare organizations on a wide range of federal and state healthcare regulatory issues. She is particularly experienced in matters impacting healthcare insurance companies, including issues related to the Centers for Medicare and Medicaid Services (CMS) requirements for Medicare and Medicaid programs, the Affordable Care Act, fraud and abuse laws and regulations, and the Health Insurance Portability and Accountability Act (HIPAA). She collaborates closely with her clients on implementing operational changes related to recent federal laws including the No Surprises Act (NSA) and the Transparency in Coverage Rule. Read Fabiola Díaz Vera's full bio.
Brian Stimson is the former Acting General Counsel and Principal Deputy General Counsel (second-ranking lawyer) for the US Department of Health and Human Services (HHS) in Washington, DC. He represents health and life sciences clients in litigations, arbitrations and government investigations nationwide. As part of his practice, Brian counsels clients on how to navigate complex disputes that present overlapping legal, regulatory, public policy and business considerations. His collaborative and pragmatic approach draws on his work as a high-level HHS official and a litigator. Read Brian Stimson's full bio.
Fabiola Díaz Vera
Fabiola Díaz Vera counsels healthcare organizations on a wide range of federal and state healthcare regulatory issues. She is particularly experienced in matters impacting healthcare insurance companies, including issues related to the Centers for Medicare and Medicaid Services (CMS) requirements for Medicare and Medicaid programs, the Affordable Care Act, fraud and abuse laws and regulations, and the Health Insurance Portability and Accountability Act (HIPAA). She collaborates closely with her clients on implementing operational changes related to recent federal laws including the No Surprises Act (NSA) and the Transparency in Coverage Rule. Read Fabiola Díaz Vera's full bio.
Related Posts
- GAO Releases Report on Telehealth
- Federal Government to Wind Down Vaccination Mandates
- HHS Issues Proposed Rule Under Section 1557 of the Affordable Care Act: Nondiscrimination in Health Programs and Activities
- Biden Administration Foreshadows Impending Nursing Home Quality Reforms
- Healthcare Preview for the Week of May 1, 2023
BLOG EDITORS
STAY CONNECTED
TOPICS
ARCHIVES
RECENT POSTS
- Will the Affordable Care Act Survive a Trump Presidency?
- DOJ Proposes Restrictions on Transactions Involving Bulk Sensitive Data, Including Health Data
- Virtual Care Policy Update: What to Expect in Lame Duck
- Unpacking the Over-the-Counter Contraception Proposed Rule
- IRS Releases Regulatory Notices Related to Health Plan Coverage of Contraceptives